Printer Friendly

GLAXO TO OFFER PRICE DISCOUNTS TO PUBLIC HEALTH CLINICS

 GLAXO TO OFFER PRICE DISCOUNTS TO PUBLIC HEALTH CLINICS
 RESEARCH TRIANGLE PARK, N.C., Feb. 4 /PRNewswire/ -- Glaxo Inc.


announced today that it would offer price discounts to public health clinics serving the poor, extending its effort to ensure patients' access to its medicines regardless of ability to pay.
 Since 1984, under the company's indigent patient program, Glaxo has been providing its drugs without charge to patients who cannot afford to pay for them.
 Now, in another effort to ensure the accessibility of its prescription drugs, Glaxo will offer 15 percent discounts to qualifying clinics funded under the Public Health Service Act, including community health centers, migrant health centers and centers serving the homeless. To qualify for the discounts, the clinics are asked to purchase medicines directly from Glaxo and assure that all Glaxo products are available to patients. The program becomes effective May 1.
 The discounts will apply to outpatient prescription drugs purchased by the centers for patients not covered by Medicaid or other programs for the indigent and elderly that already receive discounts from Glaxo. The clinics serve about 6 million people annually. Savings to the public health service clinics are expected to be about $10 million a year.
 Glaxo also reconfirmed its policy to keep price increases in line with the general inflation rate. Glaxo's pledge to limit price increases to the general inflation rate continues a trend begun by the company in the 1990/91 fiscal year. In that year, the overall price increase for all Glaxo products was 3.7 percent -- well below the increase in the general Consumer Price Index of 4.6 percent. Including the Medicaid rebates in the calculation, Glaxo's overall increase for fiscal 1990/91 was 1.5 percent.
 The company said it will continue its work to ensure that no patients are denied medicines based on their economic status.
 -0- 2/4/92
 /CONTACT: Rick Sluder, Corporate Communications, Glaxo Inc., 919-248-2839/ CO: Glaxo Inc. ST: North Carolina IN: MTC HEA SU: PDT


DF -- CH004 -- 6608 02/04/92 10:45 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 4, 1992
Words:341
Previous Article:NATIONAL CENTER FOR SUPERCOMPUTING APPLICATIONS (NCSA) ORDERS A CONVEX C3880 SUPERCOMPUTER
Next Article:DELL CONTINUES AGGRESSIVE PRICING STRATEGY IN '92; SYSTEM PRICES REDUCED BY UP TO 38 PERCENT; REDUCTIONS AS HIGH AS 47 PERCENT ON PERIPHERALS
Topics:


Related Articles
SYNTEX EXTENDS DISCOUNTED PRICES TO FEDERALLY FUNDED PUBLIC HEALTH SERVICE CENTERS
SEARLE ANNOUNCES SPECIFICS OF DISCOUNT PRICING TO PUBLIC HEALTH SERVICE CLINICS
GLAXO BEGINS SHIPPING MATERNAL AND INFANT HEALTH UNITS TO NORTH CAROLINA COUNTIES
SANDOZ ANNOUNCES PRICE REDUCTION TO VETERANS ADMINISTRATION, PUBLIC HEALTH SERVICE AND OTHER FEDERAL CLINICS
Abbott Northwestern Hospital's Clinic 42 Participates in New HIV Drug Trial
Glaxo Wellcome Inc. Announces Child Health Recognition Award Winners in North Carolina.
AIDS Healthcare Foundation drops pricing lawsuit against Glaxo.
Summer price spike: a case study about publicly funded clinics and the cost of contraceptive supplies.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters